MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
160 hedge funds and large institutions have $1.56B invested in Momenta Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 53 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 21
Holders
160
Holding in Top 10
1
Calls
$2.62M
Puts
$969K
Top Buyers
| 1 | +$75.7M | |
| 2 | +$59.7M | |
| 3 | +$18.9M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$18M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.24M |
Top Sellers
| 1 | -$104M | |
| 2 | -$12.1M | |
| 3 | -$9.07M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$6.32M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$4.8M |